{
    "clinical_study": {
        "@rank": "88950", 
        "arm_group": [
            {
                "arm_group_label": "Perinatally HIV-infected adolescents", 
                "description": "Perinatally HIV-infected adolescents"
            }, 
            {
                "arm_group_label": "behaviorally HIV-infected adolescents", 
                "description": "behaviorally HIV-infected adolescents"
            }, 
            {
                "arm_group_label": "HIV negative adolescents", 
                "description": "HIV negative adolescents"
            }
        ], 
        "biospec_descr": {
            "textblock": "Cervical and anal pap smears specimens will be used for HPV typing. Blood will be collected\n      for STI and immune response to HPV/HIV testing"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study will assess the prevalence of HPV infection in perinatally HIV-infected\n      adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites."
        }, 
        "brief_title": "HPV in Adolescents", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "HPV Infection", 
            "Cervical/Anal Dysplasia"
        ], 
        "condition_browse": {
            "mesh_term": "Carcinoma in Situ"
        }, 
        "detailed_description": {
            "textblock": "Human Papillomavirus (HPV) is the most common sexually transmitted disease and it causes\n      cervical and anal cancer. Prevalence and incidence of HPV infection among young adults who\n      are sexually experienced is high. No data exist for HIV-positive adolescents in regards to\n      HPV infection, cervical and anal intraepithelial neoplasia. This study will compare the\n      prevalence of HPV infection, intraepithelial neoplasia and E6/E7 biomarker at cervical and\n      anal sites among perinatally HIV-infected adolescents, behaviorally HIV-infected\n      adolescents, and HIV-negative adolescents."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Perinatally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic\n             acid testing (NAT) at any time and history of maternal HIV infection)\n\n          -  behaviorally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic\n             acid testing (NAT) at any time after sexual debut without history of maternal HIV\n             infection)\n\n          -  female with vaginal or receptive anal intercourse with a male OR male with receptive\n             rectal intercourse with another male\n\n          -  Signed informed consent. Volunteers aged 12-17 years can decide whether they wish for\n             their parents to consent for their participation. Due to the confidential nature of\n             the issues being studied, parental consent may be exempted\n\n        Exclusion Criteria:\n\n          -  Have any conditions that may interfer with subjects' ability to understand and\n             consent to the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "24 Years", 
            "minimum_age": "12 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "A total of 60 sexually active adolescents (perinatally and behaviorally HIV-infected\n        adolescents, HIV negative adolescents) aged 12-24 will be recruited from the HIV-NAT and\n        TRC Anonymous Clinic"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788852", 
            "org_study_id": "HIV-NAT 139"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HPV", 
            "HIV", 
            "cervical/anal dysplasia", 
            "intraepithelial neoplasia", 
            "E6/E7 biomarker", 
            "perinatally HIV-infected adolescents", 
            "behaviorally HIV-infected adolescents", 
            "anal and pap smear"
        ], 
        "lastchanged_date": "February 8, 2013", 
        "link": {
            "description": "HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)'s website", 
            "url": "http://www.hivnat.org"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10330"
                    }, 
                    "name": "HIV-NAT"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10330"
                    }, 
                    "name": "Thai Red Cross - Anonymous Clinc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10330"
                    }, 
                    "name": "Department of Pediatrics, Chulalongkorn University"
                }
            }
        ], 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_groups": "3", 
        "official_title": "Prevalence of HPV and Intraepithelial Neoplasia Biomarkers in Adolescents", 
        "overall_official": [
            {
                "affiliation": "The HIV Netherlands Australia Thailand Research Collaboration", 
                "last_name": "Jintanat Ananworanich, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Thai Red Cross AIDS Research Centre", 
                "last_name": "Nittaya Phanuphak, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Prevalence of cervical and anal HPV infection and of oncogenic subtypes, among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIv-negative adolescents", 
            "measure": "HPV infection", 
            "safety_issue": "Yes", 
            "time_frame": "48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788852"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The HIV Netherlands Australia Thailand Research Collaboration", 
            "investigator_full_name": "Jintanat Ananworanich", 
            "investigator_title": "MD., Ph.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Prevalence of intraepithelial neoplasia among the three study groups and in male and female subjects", 
                "measure": "intraepithelial neoplasia", 
                "safety_issue": "Yes", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Prevalence of detected E6/E7 biomarker among the tree study groups and in male and female subjects.\nCorrelation between detected E6/E7 and presence of HPV infection and/or intraepithelial neoplasia Association between HAART use, CD4 counts, plasma HIV RNA level and HIV clinical staging with HPV infection, intraepithelial neoplasia and E6/E7 detection", 
                "measure": "E6/E7", 
                "safety_issue": "Yes", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Proportion of adolescents who would benefit from the current preventive vaccine (i.e. those who have not been infected with oncogenic HPV subtypes 16 and 18)", 
                "measure": "HPV vaccine", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }
        ], 
        "source": "The HIV Netherlands Australia Thailand Research Collaboration", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Thai Red Cross AIDS Research Centre", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chulalongkorn University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "South East Asia Research Collaboration with Hawaii", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "We Understand Group", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "TREAT Asia", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The HIV Netherlands Australia Thailand Research Collaboration", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}